Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 295

1.

Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST study.

Cooper A, Drake J, Brankin E; PERSIST Investigators.

Int J Clin Pract. 2006 Aug;60(8):896-905. Epub 2006 Jun 19.

2.

Efficacy and tolerability of once-monthly oral ibandronate (150 mg) and once-weekly oral alendronate (70 mg): additional results from the Monthly Oral Therapy With Ibandronate For Osteoporosis Intervention (MOTION) study.

Emkey R, Delmas PD, Bolognese M, Borges JL, Cosman F, Ragi-Eis S, Recknor C, Zerbini CA, Neate C, Sedarati F, Epstein S.

Clin Ther. 2009 Apr;31(4):751-61. doi: 10.1016/j.clinthera.2009.04.018.

PMID:
19446148
3.
4.
5.

Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO).

Emkey R, Koltun W, Beusterien K, Seidman L, Kivitz A, Devas V, Masanauskaite D.

Curr Med Res Opin. 2005 Dec;21(12):1895-903.

PMID:
16368038
7.

Treatment preference for monthly oral ibandronate and weekly oral alendronate in women with postmenopausal osteoporosis: A randomized, crossover study (BALTO II).

Hadji P, Minne H, Pfeifer M, Bourgeois P, Fardellone P, Licata A, Devas V, Masanauskaite D, Barrett-Connor E.

Joint Bone Spine. 2008 May;75(3):303-10. Epub 2007 Oct 22.

PMID:
18069036
8.

Once-monthly oral ibandronate in postmenopausal osteoporosis: translation and updated review.

Rossini M, Viapiana O, Gatti D, Adami S.

Clin Ther. 2009 Jul;31(7):1497-510. doi: 10.1016/j.clinthera.2009.07.018. Review.

PMID:
19695399
9.
10.

Risk of severe gastrointestinal events in women treated with monthly ibandronate or weekly alendronate and risedronate.

Blumentals WA, Harris ST, Cole RE, Huang L, Silverman SL.

Ann Pharmacother. 2009 Apr;43(4):577-85. doi: 10.1345/aph.1L555. Epub 2009 Mar 24.

PMID:
19318598
11.
12.

Preference for weekly and monthly bisphosphonates among patients with postmenopausal osteoporosis: results from the Croatian PROMO Study.

Kastelan D, Lozo P, Stamenkovic D, Miskic B, Vlak T, Kolak Z, Milas Ahic J, Altabas V, Crncevic Orlic Z, Korsic M.

Clin Rheumatol. 2009 Mar;28(3):321-6. doi: 10.1007/s10067-008-1039-1. Epub 2008 Nov 25.

PMID:
19031095
13.

Once-monthly dosing: an effective step forward.

Reid DM.

Bone. 2006 Apr;38(4 Suppl 1):S18-22. Epub 2006 Mar 13. Review.

PMID:
16533625
14.
15.

Differences in persistence among different weekly oral bisphosphonate medications.

Sheehy O, Kindundu CM, Barbeau M, LeLorier J.

Osteoporos Int. 2009 Aug;20(8):1369-76. doi: 10.1007/s00198-008-0795-8. Epub 2008 Nov 20.

PMID:
19020921
16.

The non-interventional BonViva Intravenous Versus Alendronate (VIVA) study: real-world adherence and persistence to medication, efficacy, and safety, in patients with postmenopausal osteoporosis.

Hadji P, Felsenberg D, Amling M, Hofbauer LC, Kandenwein JA, Kurth A.

Osteoporos Int. 2014 Jan;25(1):339-47. doi: 10.1007/s00198-013-2515-2. Epub 2013 Oct 3.

PMID:
24091594
17.

Monthly oral ibandronate is effective and well tolerated after 3 years: the MOBILE long-term extension.

Stakkestad JA, Lakatos P, Lorenc R, Sedarati F, Neate C, Reginster JY.

Clin Rheumatol. 2008 Aug;27(8):955-60. doi: 10.1007/s10067-007-0824-6. Epub 2008 Jan 8.

PMID:
18180976
18.

Risk of fracture in women treated with monthly oral ibandronate or weekly bisphosphonates: the eValuation of IBandronate Efficacy (VIBE) database fracture study.

Harris ST, Reginster JY, Harley C, Blumentals WA, Poston SA, Barr CE, Silverman SL.

Bone. 2009 May;44(5):758-65. doi: 10.1016/j.bone.2009.01.002. Epub 2009 Jan 9.

PMID:
19168160
19.

Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate.

McClung M, Recker R, Miller P, Fiske D, Minkoff J, Kriegman A, Zhou W, Adera M, Davis J.

Bone. 2007 Jul;41(1):122-8. Epub 2007 Mar 24.

PMID:
17468062
20.

Beyond daily dosing: clinical experience.

Cooper C.

Bone. 2006 Apr;38(4 Suppl 1):S13-7. Epub 2006 Mar 7. Review.

PMID:
16520105
Items per page

Supplemental Content

Write to the Help Desk